Wen, Liangbao
9  results:
Search for persons X
?
1

Poor Karnofsky performance status is not a contraindication..:

Liang, Lun ; Wen, Liangbao ; Qin, Shixing...
Journal of Neuro-Oncology.  162 (2023)  2 - p. 327-335 , 2023
 
?
3

Ruboxistaurin maintains the bone mass of subchondral bone f..:

Pang, Cong ; Wen, Liangbao ; Lu, Xuanyuan...
Biomedicine & Pharmacotherapy.  131 (2020)  - p. 110650 , 2020
 
?
5

Sotrastaurin, a PKC inhibitor, attenuates RANKL‐induced bon..:

Pang, Cong ; Wen, Liangbao ; Qin, Haikuo...
Journal of Cellular and Molecular Medicine.  24 (2020)  15 - p. 8452-8465 , 2020
 
?
6

Poor Karnofsky performance status is not a contraindication..:

Liang, Lun ; Wen, Liangbao ; Qin, Shixing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167153/.  , 2023
 
?
 
?
8

Ruboxistaurin maintains the bone mass of subchondral bone f..:

Cong Pang ; Liangbao Wen ; Xuanyuan Lu...
http://www.sciencedirect.com/science/article/pii/S075333222030843X.  , 2020
 
1-9